Generic Pharmaceuticals

112 posts

AI and Machine Learning in Pharmaceutical Drug Development – Asrar Qureshi’s Blog Post #1102

The blog post by Asrar Qureshi discusses the transformative impact of Artificial Intelligence (AI) and Machine Learning (ML) on the pharmaceutical industry. It highlights innovations in drug discovery, preclinical development, clinical trials, and manufacturing, emphasizing efficiency and personalized medicine. However, challenges like data privacy and regulatory uncertainty must be addressed.
Share
View Post
  • 5 min

Colossal Wrongdoings by Big Pharma – Ranbaxy Scandal – Asrar Qureshi’s Blog Post #1093

The Ranbaxy scandal illustrates significant fraud within a major Indian pharmaceutical company that misled regulatory bodies and compromised drug safety. Whistleblower Dinesh Thakur’s revelations led to a $500 million settlement, exposing flaws in oversight and raising questions about generics. It’s a vital lesson on ethical standards and regulatory vigilance in the industry.
Share
View Post
  • 5 min

Medicines Consumption in Pakistan – Asrar Qureshi’s Blog Post #1017

Asrar Qureshi’s blog highlights the thriving yet monopolized pharmaceutical industry in Pakistan, noting a 20% growth in FY 2023-2024. While the availability of medicines has improved, affordability remains a concern amid rising prices. The country faces chronic health issues and environmental challenges, impacting healthcare dynamics and patient access.
Share